Recommended

Discover how to overcome low affinity or poor TCR yields that are slowing you down in this upcoming webinar – register your details today
WEBINAR | Discover how advances can expand the possibilities for drug discovery, from target validation to preclinical development
Facing roadblocks in obesity drug discovery? Discover how integrated, validated strategies are helping teams accelerate development and reduce risk – register your details now
Unlock the science, strategy and real-world impact behind the next generation of precision therapies – access our new brand report now >>
Safety data is no longer just a regulatory checkbox – it’s a strategic advantage. Find out more in our upcoming webinar, register your details today
WEBINAR | Join top cancer researchers to explore advances transforming early discovery, from new targets and models to the therapies of tomorrow
news

Bile duct organoids could be used as cell therapy for regenerative medicine

For the first time, scientists have grown bile duct organoids that could repair damaged ducts and livers as a new cell therapy.

Bile duct

Scientists report that they have grown bile duct organoids in the lab and shown that these can be used to repair damaged human livers. The study was conducted at the University of Cambridge, UK. 

According to the team, this research paves the way for cell therapies to treat liver disease – growing ‘mini-bile ducts’ in the lab as replacement parts that can be used to restore a patient’s own liver to health – or to repair damaged organ donor livers, so that they can still be used for transplantation. As approaches to increase organ availability or provide an alternative to whole organ transplantation are urgently needed, cell-based therapies could provide an alternative.

In their study, the scientists developed a novel approach that takes advantage of a ‘perfusion system’ to maintain donated organs outside the body. Using single-cell RNA sequencing and organoid culture, the researchers discovered that, although duct cells differ, biliary cells from the gallbladder, which is usually spared by the disease, could be converted to the cells of the bile ducts usually destroyed in disease (intrahepatic ducts) and vice versa using bile acid. This means that the patient’s own cells from disease-spared areas could be used to repair destroyed ducts.

 

access your free copy

 


Biomarkers are redefining how precision therapies are discovered, validated and delivered. 

This exclusive expert-led report reveals how leading teams are using biomarker science to drive faster insights, cleaner data and more targeted treatments – from discovery to diagnostics.

Inside the report:

  • How leading organisations are reshaping strategy with biomarker-led approaches
  • Better tools for real-time decision-making – turning complex data into faster insights
  • Global standardisation and assay sensitivity – what it takes to scale across networks

Discover how biomarker science is addressing the biggest hurdles in drug discovery, translational research and precision medicine – access your free copy today

 

They then grafted these gallbladder organoids into mice and found that they were able to repair damaged ducts, opening up avenues for regenerative medicine applications in the context of diseases affecting the biliary system.

As proof-of-principle for their method, they repaired livers deemed unsuitable for transplantation due to bile duct damage. The team then showed for the first time that it is possible to transplant biliary cells grown in the lab known as cholangiocytes into damaged human livers to repair them.

Professor Ludovic Vallier, joint senior author, said: “This is the first time that we have been able to show that a human liver can be enhanced or repaired using cells grown in the lab. We have further work to do to test the safety and viability of this approach, but hope we will be able to transfer this into the clinic in the coming years.”

The study was published in Science.